Johnson & Johnson Subsidiary Loses US Bankruptcy Bid

Global News

Johnson & Johnson subsidiary loses US bankruptcy bid

A US federal appeals court in Philadelphia has denied pharma giant Johnson & Johnson’s (J&J) subsidiary’s bankruptcy petition, which aimed to transfer thousands of legal claims against its subsidiary LTL management regarding the claim that its talcum powder causes cancer.

The three-judge panel ruled in favour of the cancer victims who stated that J&J wrongly put LTL management into bankruptcy, allowing it court protection, so courts were unable to hear the 40,000 claims against it.

This method has been called the ‘Texas Two-Step Bankruptcies’, where companies create a subsidiary to absorb the liabilities then file under Chapter 11 for bankruptcy. J&J is one of four giant companies to try to use this method.

J&J has already lost a number of similar cases, including one that was escalated to the Supreme Court and ended with J&J paying more that $2bn to one group of victims. Following this most recent loss, J&J will potentially have to pay further huge sums in court fees and payouts to claimants.

Judge Thomas Ambro wrote, ‘Good intentions ‒ such as to protect the Johnson & Johnson brand or comprehensively resolve litigation ‒ do not suffice alone [to file for bankruptcy]. What counts to access the Bankruptcy Code’s safe harbour is to meet its intended purposes. Only a putative debtor in financial distress can do so. LTL was not. Thus, we dismiss its petition.’

J&J has said it will appeal the ruling, and that its bankruptcy was filed in good faith to “equitably resolve” the talcum powder claims. This appeal will first go to a full panel at the Philadelphia appeals court, and will then be escalated to the Supreme Court if an agreement cannot be reached.

First Indian Intranasal COVID-19 Vaccine Recently Launched

Bharat Biotech has recently launched its new intranasal COVID-19 vaccine iNCOVACC

Australia’s TGA Approves Psychedelics To Treat Mental Health Conditions

The TGA has announced its approval of the use of psychedelics to treat certain mental health conditions

Drug-resistant Bacterium Found In Eye Drops Has Infected 55 People In 12 States

A strongly drug-resistant bacterium has been found in various brands of artificial tears eye drops, infecting 55 people throughout 12 states

WHO Issues A ‘Call To Action’ After Cough Syrup Deaths

WHO has issued a 'call to action' to all member states in order to try to prevent, detect and respond to incidences of illegitimate medical products

Stand Up To Cancer Announces Four Teams Dedicated To Increasing Diversity In Clinical Trials

SU2C has announced four teams focusing on increasing diversity in early phase cancer clinical trials

First Indian Intranasal COVID-19 Vaccine Recently Launched

Australia’s TGA Approves Psychedelics To Treat Mental Health Conditions

Drug-resistant Bacterium Found In Eye Drops Has Infected 55 People In 12 States

WHO Issues A ‘Call To Action’ After Cough Syrup Deaths

Stand Up To Cancer Announces Four Teams Dedicated To Increasing Diversity In Clinical Trials

Pharmafocus

Categories

Social Footprints